Literature DB >> 12758241

Prospective trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas.

Kazuhiko Ogawa1, Yoshihiko Yoshii, Osamu Inoue, Takafumi Toita, Atsushi Saito, Yasumasa Kakinohana, Genki Adachi, Yasunari Ishikawa, Shigenari Kin, Sadayuki Murayama.   

Abstract

Twenty-one patients with high-grade gliomas were enrolled in a prospective trial of radiotherapy after hyperbaric oxygenation (HBO). Radiotherapy was administered in daily 2-Gy fractions up to a total dose of 60 Gy, and each fraction was delivered immediately after HBO. The current study indicated that radiotherapy immediately after HBO with chemotherapy was feasible for high-grade gliomas.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12758241     DOI： 10.1016/s0167-8140(02)00406-1

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  10 in total

1.  Feasibility and response to 1-(4-amino-2-methyl-5-pyrimidynyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride chemotherapy with pre-treated procarbazine for elderly patients with newly diagnosed glioblastoma.

Authors:  Mizuhiko Terasaki; Toshi Abe; Naohisa Miyagi; Etsuyo Ogo; Minoru Shigemori
Journal:  J Neurooncol       Date:  2006-08-26       Impact factor: 4.130

Review 2.  New delivery approaches for pediatric brain tumors.

Authors:  Ian F Pollack; Robert Keating
Journal:  J Neurooncol       Date:  2005-12       Impact factor: 4.130

3.  Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats.

Authors:  Linda Elin Birkhaug Stuhr; A Raa; A M Oyan; K H Kalland; P O Sakariassen; K Petersen; R Bjerkvig; R K Reed
Journal:  J Neurooncol       Date:  2007-06-08       Impact factor: 4.130

4.  Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas.

Authors:  Kiyotaka Kohshi; Haruaki Yamamoto; Ai Nakahara; Takahiko Katoh; Masashi Takagi
Journal:  J Neurooncol       Date:  2006-11-22       Impact factor: 4.506

5.  Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas.

Authors:  K Ogawa; Y Yoshii; O Inoue; T Toita; A Saito; Y Kakinohana; G Adachi; S Iraha; W Tamaki; K Sugimoto; A Hyodo; S Murayama
Journal:  Br J Cancer       Date:  2006-09-05       Impact factor: 7.640

Review 6.  Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours.

Authors:  Katarzyna Stępień; Robert P Ostrowski; Ewa Matyja
Journal:  Med Oncol       Date:  2016-08-02       Impact factor: 3.064

7.  Hyperbaric oxygen increases glioma cell sensitivity to antitumor treatment with a novel isothiourea derivative in vitro.

Authors:  Katarzyna Zembrzuska; Robert P Ostrowski; Ewa Matyja
Journal:  Oncol Rep       Date:  2019-03-14       Impact factor: 3.906

Review 8.  The use of radiosensitizing agents in the therapy of glioblastoma multiforme-a comprehensive review.

Authors:  Niklas Benedikt Pepper; Walter Stummer; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2022-05-03       Impact factor: 4.033

9.  Hyperbaric Oxygen Therapy as a Complementary Treatment in Glioblastoma-A Scoping Review.

Authors:  Diogo Alpuim Costa; Mafalda Sampaio-Alves; Eduardo Netto; Gonçalo Fernandez; Edson Oliveira; Andreia Teixeira; Pedro Modas Daniel; Guilherme Silva Bernardo; Carla Amaro
Journal:  Front Neurol       Date:  2022-07-01       Impact factor: 4.086

Review 10.  Hyperbaric oxygen therapy as adjunctive strategy in treatment of glioblastoma multiforme.

Authors:  Lei Huang; Warren Boling; John H Zhang
Journal:  Med Gas Res       Date:  2018-04-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.